|
Luminal and basal subtyping of prostate cancer. |
|
|
Leadership - PFS Genomics |
Stock and Other Ownership Interests - PFS Genomics |
Consulting or Advisory Role - Celgene; GenomeDx; Medivation/Astellas |
Research Funding - Celgene; Varian Medical Systems |
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst) |
|
|
Employment - PFS Genomics (I) |
Patents, Royalties, Other Intellectual Property - GenomeDx |
Travel, Accommodations, Expenses - GenomeDx |
|
|
Employment - PFS Genomics |
|
|
|
|
|
|
|
|
|
|
|
|
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Myriad Pharmaceuticals |
Research Funding - GenomeDx (Inst); Genomic Health (Inst); Myriad Pharmaceuticals (Inst) |
|
|
Consulting or Advisory Role - Bayer; Dendreon; Genentech |
Research Funding - Novartis |
|
|
Honoraria - Astellas Pharma; Janssen Oncology |
Consulting or Advisory Role - Bayer; Millennium |
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis |
|
|
Consulting or Advisory Role - GenomeDx |
|
Research Funding - GenomeDx; Medivation/Astellas |
Travel, Accommodations, Expenses - GenomeDx |
|
|
Stock and Other Ownership Interests - Armune Bioscience; Parallel6 |
Consulting or Advisory Role - Armune Bioscience; Astellas Pharma; Bayer; Dendreon; GenomeDx; Janssen Biotech; MDxHealth; Medivation; Parallel6; Sanofi |
Speakers' Bureau - Dendreon |
Research Funding - Amgen (Inst); Bayer (Inst); Dendreon (Inst); GenomeDx (Inst); Janssen Biotech (Inst); Metabolon (Inst); Mitomics (Inst); Myriad Genetics (Inst); POM Wonderful (Inst); Progenika (Inst) |
Travel, Accommodations, Expenses - GenomeDx; Myriad Genetics; Sanofi |
|
|
|
Research Funding - Janssen; Medivation/Astellas; TRACON Pharma |
|
|
Consulting or Advisory Role - Berg Pharma |
Speakers' Bureau - GenomeDx; Genomic Health |
|
|
|
|
Stock and Other Ownership Interests - GenomeDx |
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323 |
Travel, Accommodations, Expenses - GenomeDx |
|
|
Stock and Other Ownership Interests - GenomeDx |
Honoraria - Healthtronics |
Consulting or Advisory Role - Healthtronics |
Research Funding - metamark genetics |
|
|
Consulting or Advisory Role - GenomeDx; Myriad Genetics |
|
|
Consulting or Advisory Role - Ferring; GenomeDx; Medivation |
Research Funding - Astellas Pharma |
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I) |
|
|
Honoraria - Genomic Health; Takeda |
Consulting or Advisory Role - Janssen; Medivation |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |